Do you provide Good Laboratory Practice Support?
How Good Laboratory Practice support works in a safety study
GLP is a quality system for how a study is organised and documented. It applies to the non-clinical safety studies an authority will rely on, and it sits alongside the test guideline that defines the method, for example an OECD in vitro sensitisation or genotoxicity guideline. A GLP study follows both.
Study set-up
Each study has a study director who holds overall responsibility. Before work begins, the study director signs a study plan that defines the test item, the test system, the guideline followed, the endpoints and the schedule. The test item is characterised and recorded, and the sponsor supplies or confirms its identity, batch, purity and stability.
Records generated during the study
- Signed study plan and any amendments
- Test item receipt, storage and use records
- Standard operating procedures in force
- Equipment calibration and maintenance logs
- Contemporaneous, attributable raw data
- Deviation reports signed by the study director
Quality assurance and reporting
An independent quality assurance unit inspects critical phases of the study and audits the final report against the raw data. The final report carries the study director’s GLP compliance statement and the QA statement listing inspection dates. Raw data, specimens and the report are then held in a controlled archive for the retention period set by the applicable national regulations.
What the sponsor receives
You receive the signed GLP final report with both statements, a description of any deviations and their impact, and confirmation of where the raw data and specimens are archived. Support consultants can also audit a facility on your behalf, review study plans before signature and prepare the study for inclusion in a regulatory file.
When cosmetic studies need Good Laboratory Practice support
GLP is ordered study by study, according to who will receive the data and what decision they will base on it.
Deciding whether GLP is required
Start from the receiving authority. Ingredient safety data for an SCCS opinion, a REACH registration or a Chinese new-ingredient registration is normally expected to come from GLP studies. Finished-product work such as stability, preservative efficacy and in-use consumer studies is usually run in ISO/IEC 17025 accredited laboratories or, for human studies, under good clinical practice. GLP adds cost there without changing how the data are received.
Choosing a GLP test facility
Ask for the facility’s current statement of GLP compliance from its national monitoring authority and check that the scope covers the study type you need, for example in vitro toxicology or analytical chemistry. Check the date of the last inspection. For in vitro methods, ask whether the laboratory has run the specific OECD guideline before and can show historical control data, since reviewers compare your results against them.
Using the report in a dossier
A GLP final report slots directly into ingredient safety files and the toxicological section of a safety dossier. When the authority asks for the underlying results, the archived records can be exported as submission data files.
More in Submission Documentation
Cosmetic regulatory submission data and technical report translation turn study reports into translated, traceable files an authority can accept.


